HC Wainwright & Co. Initiates Coverage On Processa Pharma With Buy Rating, Announces Price Target of $8
HC Wainwright & Co. Initiates Coverage On Processa Pharma With Buy Rating, Announces Price Target of $8
HC Wainwright & Co.以買入評級啓動對Processa Pharma的報道,宣佈目標股價爲8美元
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on Processa Pharma (NASDAQ:PCSA) with a Buy rating and announces Price Target of $8.
HC Wainwright & Co. 分析師拉古拉姆·塞爾瓦拉朱以買入評級啓動了對Processa Pharma(納斯達克股票代碼:PCSA)的報道,並宣佈目標股價爲8美元。
譯文內容由第三人軟體翻譯。
以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。